Search Results 111-120 of 16151 for anti-TNF drugs
... agents and small-molecule drugs, early in the course of disease. ... Examining clinical and genetic factors that impact response to anti-TNF agents in patients ...
Anti-TNF therapy in the 2 weeks before the week 0 visit; Failure of cyclosporine therapy in the previous 6 months prior to screening visit; Serum albumin ...
... anti-inflammatory drugs (NSAIDs), aspirin and several supplements in preventing the recurrence of advanced neoplasia (polyps that are the precursor of ...
Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD. MAC-20491375. Medical Professionals; Comparing modalities ...
Prior treatment failure or intolerance with at least one Anti-Tumor Necrosis-Factor-Alpha Therapy (anti-TNF α) agent; Effective contraception from screening ...
Testing the Addition of an Anti-cancer Drug, ASTX727, to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast ...
Known anti-human anti-chimeric antibody formation; Treatment with infliximab, adalimumab, or etanercept within the past 12 months. Currently taking ...
Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD. MQC-20526540. Medical Professionals; The role of capsule ...
Look up information about prescription drugs, over-the-counter medications, herbs, vitamins and supplements.
... anti-TNF therapy (poster presentation). European League Against Rheumatism (EULAR).2004;; Peterson LS, Mason T, Mason T, Nelson AM, O'Fallon WM, Gabriel SE ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift that can go twice as far to advance healthcare research.